Join stem cell physician scientist Dr. James L. Sherley and interviewer Jordan Rich in the final podcast episode for a look forward to a new era of stem cell medicine advanced by stem cell counting. Dr. Sherley invites others to join in his vision of future in which stem cell science and stem cell medicine … Continue reading The Future Vision for Tissue Stem Cell Counting -006 →

In the fifth episode, Asymmetrex director James L. Sherley and interviewer Jordan Rich expand their discussion of stem cell counting for stem cell medicine to consider how both traditional pharmaceutical drug development and environmental health analyses will also benefit from the new technology.

Continue the conversation with interviewer Jordan Rich and stem cell scientist Dr. James Sherley as they discuss a new technology that provides a solution for the stem cell counting problem. Beyond the technology and how it works, they begin to consider how it can improve stem cell medicine, in both FDA-authorized clinical trials and private … Continue reading The Stem Cell Counting Problem: A Solution -004 →

In episode three, Jordan Rich asks Asymmetrex founder and director Dr. James L. Sherley if the stem cell counting problem really matters for stem cell medicine. Listen in for Dr. Sherley’s response.

Listen in as stem cell physician scientist Dr. James Sherley and interviewer Jordan Rich pick up their exploration together on how stem cell medicine works. Their conversation reveals a pervasive, but often unacknowledged, problem in stem cell medicine that limits its effectiveness.

In this first episode, Dr. James Sherley talks with Jordan Rich about how stem cells are used for medicine, and they consider the tension between FDA-authorized clinical trials and treatments in private stem cell clinics.  Their discussion discloses a bigger problem that compromises all stem cell treatments, even approved ones.